The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease

Neuroscience Letters

Volumn 330, Issue 2, 2002, Pages 201-203

  De Silva, Rohan ^a,b   Hardy, John ^a,c,d   Crook, Julia ^c   Khan, Naheed ^b   Graham, Elizabeth A ^b   Morris, Christopher M ^e   Wood, Nicholas W ^b   Lees, Andrew J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MAYO GRADUATE SCHOOL   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Genetics; Neurodegeneration; Parkinson's disease; Tau

Indexed keywords

TAU PROTEIN;

ARTICLE; BRAIN STEM; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; GENE LOCUS; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TAU PROTEINS;

EID: 0037144188     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00742-5     Document Type: Article

References (16)

1. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8:1999;711-715.
2. de Silva R., Weiler M., Morris H.R., Martin E.R., Wood N.W., Lees A.J. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. Neurosci. Lett. 311:2001;145-148.
3. Di Maria E., Tabaton M., Vigo T., Abbruzzese G., Bellone E., Donati C., Frasson E., Marchese R., Montagna P., Munoz D.G., Pramstaller P.P., Zanusso G., Ajmar F., Mandich P. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol. 47:2000;374-377.
4. Farrer M., Skipper L., Berg M., Bisceglio G., Hanson M., Hardy J., Adam A., Gwinn-Hardy K., Aasly J. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. Neurosci. Lett. 322:2002;83-86.
5. Gibb W.R.G., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 51:1988;745-752.
6. Golbe L.I., Lazzarini A.M., Spychala J.R., Johnson W.G., Stenroos E.S., Mark M.H., Sage J.I. The tau A0 allele in Parkinson's disease. Mov. Disord. 16:2001;442-447.
7. Hoenicka J., Perez M., Perez-Tur J., Barabash A., Godoy M., Vidal L., Astarloa R., Avila J., Nygaard T., de Yebenes J.G. The tau gene A0 allele and progressive supranuclear palsy. Neurology. 53:1999;1219-1225.
8. Houlden H., Baker M., Morris H.R., MacDonald N., Pickering-Brown S., Adamson J., Lees A.J., Rossor M.N., Quinn N.P., Kertesz A., Khan M.N., Hardy J., Lantos P.L., St.George-Hyslop P., Munoz D.G., Mann D., Lang A.E., Bergeron C., Bigio E.H., Litvan I., Bhatia K.P., Dickson D., Wood N.W., Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 56:2001;1702-1706.
9. Hughes A.J., Daniel S.E., Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 57:2001;1497-1499.
10. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., Van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
11. Maraganore D.M., Hernandez D.G., Singleton A.B., Farrer M.J., McDonnell S.K., Hutton M.L., Hardy J.A., Rocca W.A. Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann. Neurol. 50:2001;658-661.
12. Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H. Jr., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Ribble R.C., Booze M.W., Rogala A., Hauser M.A., Zhang F., Gibson R.A., Middleton L.T., Roses A.D., Haines J.L., Scott B.L., Pericak-Vance M.A., Vance J.M. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. J. Am. Med. Assoc. 286:2001;2245-2250.
13. Morris H.R., Janssen J.C., Bandmann O., Daniel S.E., Rossor M.N., Lees A.J., Wood N.W. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry. 66:1999;665-667.
14. Pastor P., Ezquerra M., Munoz E., Marti M.J., Blesa R., Tolosa E., Oliva R. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann. Neurol. 47:2000;242-245.
15. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43:1998;815-825.
16. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA. 95:1998;7737-7741.